Skip to Main Content

Author Details

Christopher C Benz
Buck Institute for Research on Aging
1977
224
68
PMIDPaper TitleJournal TitlePublished Year
37586438Therapeutic targeting of HYPDH/PRODH2 with N-propargylglycine offers a Hyperoxaluria treatment opportunity.Biochim Biophys Acta Mol Basis Dis2024
37586438Therapeutic targeting of HYPDH/PRODH2 with N-propargylglycine offers a Hyperoxaluria treatment opportunity.Biochim Biophys Acta Mol Basis Dis2024
36331687A common IGF1R gene variant predicts later life breast cancer risk in women with preeclampsia.Breast Cancer Res Treat2023
36331687A common IGF1R gene variant predicts later life breast cancer risk in women with preeclampsia.Breast Cancer Res Treat2023
37500962Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes.Breast Cancer Res Treat2023
37292628Breast cancer risk based on a deep learning predictor of senescent cells in normal tissue.medRxiv2023
37500962Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes.Breast Cancer Res Treat2023
37292628Breast cancer risk based on a deep learning predictor of senescent cells in normal tissue.medRxiv2023
34817747Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer.Breast Cancer Res Treat2022
35362533Reduced cardiovascular risks in women with endometriosis or polycystic ovary syndrome carrying a common functional IGF1R variant.Hum Reprod2022
35862873Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.J Clin Oncol2022
35179782Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature.Int J Cancer2022
34817747Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer.Breast Cancer Res Treat2022
35362533Reduced cardiovascular risks in women with endometriosis or polycystic ovary syndrome carrying a common functional IGF1R variant.Hum Reprod2022
35862873Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.J Clin Oncol2022
35179782Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature.Int J Cancer2022
34190995Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.JAMA Netw Open2021
34286353Correction to: N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties.Amino Acids2021
34170304Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden.JAMA Netw Open2021
33626341Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.Cell Rep2021
33824512Author Correction: MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.Nat Cell Biol2021
34089390N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties.Amino Acids2021
34190995Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.JAMA Netw Open2021
33626341Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.Cell Rep2021
33824512Author Correction: MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.Nat Cell Biol2021
34089390N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties.Amino Acids2021
34286353Correction to: N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties.Amino Acids2021
34170304Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden.JAMA Netw Open2021
32736587A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population.Breast Cancer Res2020
32736587A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population.Breast Cancer Res2020
33168159Cancer and Cardiovascular Risk in Women With Hypertensive Disorders of Pregnancy Carrying a Common IGF1R Variant.Mayo Clin Proc2020
33168159Cancer and Cardiovascular Risk in Women With Hypertensive Disorders of Pregnancy Carrying a Common IGF1R Variant.Mayo Clin Proc2020
31189611Targeting Mitochondrial Proline Dehydrogenase with a Suicide Inhibitor to Exploit Synthetic Lethal Interactions with p53 Upregulation and Glutaminase Inhibition.Mol Cancer Ther2019
31687025Pregnancy Hypertension and a Commonly Inherited IGF1R Variant (rs2016347) Reduce Breast Cancer Risk by Enhancing Mammary Gland Involution.J Oncol2019
31393518Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer.JAMA Oncol2019
31189611Targeting Mitochondrial Proline Dehydrogenase with a Suicide Inhibitor to Exploit Synthetic Lethal Interactions with p53 Upregulation and Glutaminase Inhibition.Mol Cancer Ther2019
31687025Pregnancy Hypertension and a Commonly Inherited IGF1R Variant (rs2016347) Reduce Breast Cancer Risk by Enhancing Mammary Gland Involution.J Oncol2019
31393518Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer.JAMA Oncol2019
29316429Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.Cancer Cell2018
29625055An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.Cell2018
29625048Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.Cell2018
29617660Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep2018
29301020Discovery of internalizing antibodies to basal breast cancer cells.Protein Eng Des Sel2018
29361175Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.J Natl Cancer Inst2018
29316429Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.Cancer Cell2018
29402901Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype.Sci Rep2018
29617660Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep2018
29361175Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.J Natl Cancer Inst2018
29402901Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype.Sci Rep2018
29625055An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.Cell2018
  • 1 - 50 of 448

Recommended Authors

David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 3
Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2002
Number of shared co-authors 0
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 4
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 2
Cecilia Williams
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 17
Hal K Berman
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1997
Number of shared co-authors 1
Theresa M LaVallee
Parker Institute for Cancer Immunotherapy
Career Start Year 1996
Number of shared co-authors 1
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 4
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 5
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 10
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 32
Barry R Davies
Oncology R&D
Career Start Year 1992
Number of shared co-authors 5
John M S Bartlett
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 9
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 24
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 7
Ramona F Swaby
Merck & Co., Inc.
Career Start Year 1991
Number of shared co-authors 2
Powel H Brown
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 9
Joan Albanell
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 9
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 11
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 9
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 2
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 9
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 10
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 24
Fabien Calvo
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 1
Irene L Andrulis
University of Toronto
Career Start Year 1977
Number of shared co-authors 15
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 5
Dennis J Slamon
David Geffen School of Medicine at university of california los angeles
Career Start Year 1973
Number of shared co-authors 18
Anna DeFazio
Westmead Hospital
Career Start Year 1972
Number of shared co-authors 20
Maria Mitzi Brentani
Sao Paulo University
Career Start Year 1964
Number of shared co-authors 0

Collaborators

Christina Yau
University of California San Francisco
Co-authored papers 36
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 14
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers 12
Bradford W Gibson
The Buck Institute for Research on Aging
Co-authored papers 11
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 10
Laura J Van't Veer
University of California San Francisco
Co-authored papers 10
Birgit Schilling
Buck Institute for Research on Aging
Co-authored papers 9
Peter W Laird
Van Andel Institute
Co-authored papers 9
Jason M Held
Co-authored papers 8
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers 8
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 7
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Edison T Liu
USA The Jackson Laboratory Cancer Center
Co-authored papers 6
Hui Shen
Van Andel Institute
Co-authored papers 6
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Charles M Perou
Co-authored papers 5
Tara M Lichtenberg
Co-authored papers 5
Cyriac Kandoth
University of California los angeles
Co-authored papers 5
Cindy A Hunt
University of California san francisco
Co-authored papers 5
Ronglai Shen
Co-authored papers 4
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Christopher K Wong
University of California
Co-authored papers 4
Joe W Gray
Oregon Health and Science University
Co-authored papers 4
Sam Ng
University of Adelaide
Co-authored papers 4
Charles Kent Osborne
Co-authored papers 4
Reanne Bowlby
Co-authored papers 4
Clifford A Hudis
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Co-authored papers 4
Denise M Wolf
University of California San Francisco
Co-authored papers 4
Jean Claude Zenklusen
National Cancer Institute
Co-authored papers 4
Release 1.2